Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07282444 · ClinicalTrials.gov registry record · NA

A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial

A NA study, sponsored by Wake Forest University Health Sciences.

Not yet
Registry status
NA
Development phase
194
Enrollment target

NCT07282444: Clinical Trial NA study, sponsored by Wake Forest University Health Sciences.

NCT07282444 is a NA study that has not yet begun recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 194 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07282444, a NA study, has not yet begun recruiting, sponsored by Wake Forest University Health Sciences.

NOT YET RECRUITING
Registry status
NA
Development phase
194 participants
Enrollment target

Study Summary

This clinical trial tests a new way to share radiation therapy plans using the Collaborative Oncology between Radiologists and Radiation oncologists for the Evaluation of Contoured Targets (CORRECT) workflow to improve communication and collaboration between radiation oncologists (ROs) and radiologists when determining cancer targets for radiation treatment. Systemic barriers limit critical communication between radiation oncologists and radiologists and can lead to both under and overdosing of radiation therapy (RT) tumor targets and failures to properly interpret post-treatment imaging. The limited formal diagnostic radiology training of many providers can make differentiating normal from disease imaging findings during target determination difficult, especially in complex disease sites like the lung, head, and neck. Inaccurate target determination may result in cancer return, excess toxicity, or both. Likewise, radiologists who cannot access prior RT plans may mistake expected RT changes for recurrent cancer or overlook true progression. The CORRECT workflow was developed by ROs and radiologists to address RO-radiology communication barriers by facilitating sharing of comprehensive RT target contours during RT planning. The CORRECT workflow begins with the normal process of RO target contouring. Computed tomography (CT) images are then fused with RT targets and pushed to a pre-designated Picture Archiving and Communications System (PACS) software folder accessible by the radiology department. The radiologist can then review the fused images at their chosen time and annotate images to indicate potential deviations (e.g., not avoiding normal tissue or not including all tumor). The RO reviews the annotated images and decides if any changes to treatment targets are needed for the final treatment plan. Through this independent, asynchronous review of high-quality images, CORRECT overcomes many of the limitations of existing communication methods between RO-radiologist

Primary Outcome

If \> 50% of patients have target feedback returned to the radiation oncologist within 2 business days, this workflow will be considered feasible in community practice.

Interventions

  • OTHER Survey Administration
  • OTHER Communication Intervention
  • OTHER Electronic Health Record Review
  • OTHER Interview
  • BEHAVIORAL Training and Education

Trial Details

FieldValue
Enrollment Target 194 participants
Start Date 2026-07-01
Est. Completion 2028-11-01
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What is known before NCT07282444 opens enrollment

NCT07282444 is an interventional study that assigns participants to a tested intervention. The registered 194 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 5 interventions - of which Survey Administration is the first listed.

NCT07282444 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07282444 about?

NCT07282444 is a clinical study titled "A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial". This clinical trial tests a new way to share radiation therapy plans using the Collaborative Oncology between Radiologists and Radiation oncologists for the Evaluation of Contoured Targets (CORRECT) workflow to improve communication and collaboration between radiation oncologists (ROs) and radiologi...

What is the current status of trial NCT07282444?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 194 participants. The study started on 2026-07-01. Estimated completion is 2028-11-01.

What interventions are being tested in trial NCT07282444?

The interventions under investigation include: Survey Administration (OTHER), Communication Intervention (OTHER), Electronic Health Record Review (OTHER), Interview (OTHER), Training and Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT07282444?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07282444's enrollment target sits among peer trials

194 568th of 2000 higher than 1,432 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03593759 · 194 participants · Phase 3

    Cardiac Sarcoidosis Randomized Trial

  • NCT05053152 · 194 participants · Phase 2

    Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

  • NCT05156112 · 194 participants · NA

    OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit

  • NCT05351424 · 194 participants · NA

    AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07282444, the US trial registry maintained by the National Library of Medicine. NCT07282444 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.